z
zolmitriptan
Chemical compound
Also known as (S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one · 4-{[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl}oxazolidin-2-one · 4-{[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl}oxazolidin-2-one
- Formula
- C₁₆H₂₁N₃O₂
1
- C₁₆H₂₁N₃O₂
- Mass
- 287.1634 Da
1
- 287.1634 Da
Overview
Chemistry
All data
78 statements · 71% with external sources · numbers in brackets are citations
- Significant drug interaction
- isocarboxazid
- phenelzine
- tranylcypromine
- vortioxetine side effect: geniospasm
- vortioxetine side effect: mental status change
- vortioxetine side effect: hyperthermia
- vortioxetine side effect: hypertension
- linezolid side effect: mental status change
Show 7 moreShow less
- linezolid side effect: geniospasm
- linezolid side effect: hyperthermia
- linezolid side effect: hypertension
- phenelzine side effect: mental status change
- phenelzine side effect: hypertension
- phenelzine side effect: hyperthermia
- phenelzine side effect: geniospasm
- Canonical SMILES
- CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
1
- CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
- Isomeric SMILES
- CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3
1
- CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3
- Medical condition treated
- migraine
1
Sources- 1.Stated in Drug Indications Extracted from FAERSRetrieved 2018-10-02
- migraine
- Physically interacts with
- 5-hydroxytryptamine receptor 1A subject has role: agonist
1
- 5-hydroxytryptamine receptor 1B subject has role: agonist
2
Sources- 1.Stated in IUPHAR/BPS Guide to PHARMACOLOGYRetrieved 2016-08-17
- 2.Stated in Open Targets Platformplatform.opentargets.org/drug/CHEMBL1185Retrieved 2023-08-14
- 5-hydroxytryptamine receptor 1D subject has role: agonist
2
Sources- 1.Stated in IUPHAR/BPS Guide to PHARMACOLOGYRetrieved 2016-08-17
- 2.Stated in Open Targets Platformplatform.opentargets.org/drug/CHEMBL1185Retrieved 2023-08-14
- 5-hydroxytryptamine receptor 1E subject has role: agonist
1
- 5-hydroxytryptamine receptor 1F subject has role: agonist
1
- 5-hydroxytryptamine receptor 1A subject has role: agonist
- Stylized name
- ZOLMitriptan has characteristic: Tall Man lettering · issued by: Institute for Safe Medication Practices
1
Sources- 1.ismp.org/recommendations/tall-man-letters-listRetrieved 2022-09-02
- ZOLMitriptan has characteristic: Tall Man lettering · issued by: Institute for Safe Medication Practices
- Defined daily dose
- 2.5 milligram route of administration: oral administration
On other databases
35 identifiers linking zolmitriptan across the web's reference databases
- ATC codeN02CC03
- CAS Registry Number139264-17-8
- ChEBI ID10124
- ChEMBL IDCHEMBL1185
- ChemSpider ID54844
- DrugBank IDDB00315
- DrugCentral ID2869
- DSSTOX compound identifierDTXCID6025933
- DSSTox substance IDDTXSID8045933
- EC number629-919-0
- ECHA Substance Infocard ID100.158.186
- Freebase ID/m/049yqz
- Guide to Pharmacology Ligand ID60
- Human Metabolome Database IDHMDB0014460
- InChIInChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1
- InChIKeyULSDMUVEXKOYBU-ZDUSSCGKSA-N
- KEGG IDC07218
- MassBank accession IDMSBNK-Waters-WA002407
- MedlinePlus drug identifiera601129
- MeSH descriptor IDC089750
- Microsoft Academic ID (discontinued)2779085531
- NDF-RT IDN0000148550
- NSC number760383
- OpenAlex IDC2779085531
- Probes And Drugs IDPD000525
- PubChem CID60857
- Reaxys registry number7415010
- RxNorm CUI135775
- ScienceDirect topic IDbiochemistry-genetics-and-molecular-biology/zolmitriptan
- SPLASHsplash10-000i-1390000000-5eb2470575d7a40b35dd
- SureChEMBL ID33336
- UMLS CUIC0528166
- UniChem compound ID84848
- UNII2FS66TH3YW
- WikiProjectMed IDZolmitriptan